Journals / Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi / 2022 / Cilt: 1 - Sayı: 3

Pattern Analysis and Grading in Lung Adenocarcinomas

Akciğer Adenokarsinomlarında Patern Analizi ve Derecelendirme

Pages
105–117
Publication Date
2022-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review focuses on the heterogeneous morphology of Lung adenocarcinomas

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Adenocarcinoma is the most common histological type of lung cancer.
📊
Key Findings & Data:To address advances in the oncology, molecular biology, pathology, radiology, and surgery of lung adenocarcinoma, an international multidisciplinary classification was made in 2011 by the International Society for Lung Cancer Research, the American Thoracic Society, and the European Respiratory Society.
💡
Conclusion & Impact:This review focuses on the heterogeneous morphology of Lung adenocarcinomas
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Akciğer · Adenokarsinom · Patern Analizi

Abstract

Adenocarcinoma is the most common histological type of lung cancer. The choice of treatment now holistically depends on the histological phenotype and molecular genotype. To address advances in the oncology, molecular biology, pathology, radiology, and surgery of lung adenocarcinoma, an international multidisciplinary classification was made in 2011 by the International Society for Lung Cancer Research, the American Thoracic Society, and the European Respiratory Society. In 2015, special emphasis was placed on the use of immunohistochemistry to make classification more accurate. Updated 2021 WHO classification of lung tumors. In the diagnosis of these tumors, which are clinically, pathologically and molecularly heterogeneous, based on a multidisciplinary approach, morphology supported first by immunohistochemistry and then by molecular techniques is essential. This review focuses on the heterogeneous morphology of Lung adenocarcinomas

Özet

Adenokarsinom, akciğer kanserinin en sık görülen histolojik tipidir. tedavi seçimi artık bütünsel olarak histolojik fenotipe ve moleküler genotipe bağlıdır. Akciğer adenokarsinomunun onkolojisi, moleküler biyolojisi, patolojisi, radyolojisi ve cerrahisindeki ilerlemeleri ele almak için, 2011 yılında Uluslararası Akciğer Kanseri Araştırmaları Derneği, Amerikan Toraks Derneği ve Avrupa Solunum Derneği tarafından uluslararası bir multidisipliner sınıflandırma yapıldı. 2015 yılında, sınıflandırmayı daha doğru hale getirmek için immünohistokimyanın kullanılması özellikle vurgulandı. 2021 DSÖ akciğer tümörlerinin sınıflandırılması güncellendi. Klinik, patolojik ve moleküler olarak heterojen olan bu tümörlerin multidisipliner bir yaklaşıma dayanan teşhisinde önce immünohistokimya ve ardından moleküler tekniklerle desteklenen morfoloji esastır. Bu derlemede Akciğer adenokarsinomlarının heterojen morfolojisine odaklanmaktadır

🔖

Cite This Article

ÖZMEN, S., DEMİRAĞ, F., ŞİPAL, S. (2022). Pattern Analysis and Grading in Lung Adenocarcinomas. Atatürk Üniversitesi Tıp Fakültesi Cerrahi Tıp Bilimleri Dergisi, Cilt: 1 - Sayı: 3, 105–117. https://ajindex.com/articles/873183

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Sung, H., et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 2021. 71(3): p. 209-249
  2. Sağlık Bakanlığı, T.C., Türkiye Kanser İstatistikleri. 2017, T.H.S. Kurumu, Editor. 2021, Halk Sağlığı Genel Müdürlüğü Ankara 3. Howlader, N., et al., SEER Cancer Statistics Review, 1975-2013 (p. based on November 2015 SEER data submission, posted to the SEER web site, April 2016). Bethesda, MD: National Cancer Institute. 2016
  3. Howlader, N., et al., SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD. 2020
  4. Horn, L., Pulmonary adenocarcinoma: approaches to treatment. 2018: Elsevier Health Sciences
  5. Travis, W.D., et al., The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol, 2016. 11(8): p. 1204-1223
  6. Ettinger, D.S., et al., NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. J Natl Compr Canc Netw, 2016. 14(3): p. 255-64
  7. Ge, C., et al., Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC. BMC Cancer, 2017. 17(1): p. 884
  8. Pal, P., M. Cabanero, and M.S. Tsao, Chapter 2 - Pulmonary Adenocarcinoma - Pathology and Molecular Testing, in Pulmonary Adenocarcinoma: Approaches to Treatment, L. Horn, Editor. 2019, Elsevier. p. 13-33
  9. Travis, W.D., et al., The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol, 2015. 10(9): p. 1243-1260
  10. Nicholson, A.G., et al., The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol, 2022. 17(3): p. 362-387
  11. Thway, K., et al., Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. The American journal of surgical pathology, 2011. 35(11): p. 1722-1732
  12. Saito, R., et al., Novel Histologic Classification of Small Tumor Cell Nests for Lung Adenocarcinoma With Prognostic and Etiological Significance: Small Solid Nests and Pure Micropapillary Nests. The American Journal of Surgical Pathology, 2021. 45(5): p. 604-615
  13. Xing, Y., et al., Analysis of pre‐invasive lung adenocarcinoma lesions on thin‐section computerized tomography. The clinical respiratory journal, 2015. 9